Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Toon andere (2) versies

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increa...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Brueggemann, A, Pai, R, Crook, D, Beall, B
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2007

Gelijkaardige items

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
door: Brueggemann, A, et al.
Gepubliceerd in: (2007)

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
door: Brueggemann, AB, et al.
Gepubliceerd in: (2007)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
door: Golubchik, T, et al.
Gepubliceerd in: (2012)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
door: Golubchik, T, et al.
Gepubliceerd in: (2012)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.
door: Croucher, N, et al.
Gepubliceerd in: (2014)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
door: Andrew D. Wiese, et al.
Gepubliceerd in: (2019-04-01)

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
door: Obando, I, et al.
Gepubliceerd in: (2007)

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
door: Adam L Cohen, et al.
Gepubliceerd in: (2012-01-01)

Pneumococcal Vaccination in the United States: Current Recommendations and Strategies to Improve Vaccination Coverage
door: Cynthia G Whitney
Gepubliceerd in: (1999-01-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
door: Sandra S. Richter, et al.
Gepubliceerd in: (2013-07-01)

State of pneumococcal vaccine immunity
door: Mustafa Akkoyunlu
Gepubliceerd in: (2024-12-01)

Pneumococcal Vaccines
door: D. E. Briles, et al.
Gepubliceerd in: (2019-12-01)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
door: Foster, D, et al.
Gepubliceerd in: (2008)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
door: Zhang Jian Shayne F, et al.
Gepubliceerd in: (2011-04-01)

Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
door: Salini Mohanty, et al.
Gepubliceerd in: (2025-12-01)

Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
door: Salini Mohanty, et al.
Gepubliceerd in: (2024-12-01)

Emerging vaccine strategies against the incessant pneumococcal disease
door: Jeremy A. Duke, et al.
Gepubliceerd in: (2023-08-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
door: Hiroaki Takeda, et al.
Gepubliceerd in: (2019-01-01)

Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States
door: Omotola Olasupo, et al.
Gepubliceerd in: (2020-01-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
door: Sleeman, K, et al.
Gepubliceerd in: (2001)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
door: Thijs W. Hoffman, MD, et al.
Gepubliceerd in: (2020-06-01)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
door: Licciardi, P, et al.
Gepubliceerd in: (2016)

Generalized granuloma annulare after pneumococcal vaccination,
door: Miguel Fernando García-Gil, et al.
Gepubliceerd in: (2021-03-01)

Pneumococcal vaccination in developing countries.
door: Levine, O, et al.
Gepubliceerd in: (2006)

Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
door: Salini Mohanty, et al.
Gepubliceerd in: (2024-12-01)

Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].
door: Marisol Figueira, et al.
Gepubliceerd in: (2014-01-01)

Pneumococcal vaccines in China
door: Shanshan Wang, et al.
Gepubliceerd in: (2025-12-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
door: Nobuhiro Asai, et al.
Gepubliceerd in: (2021-11-01)

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
door: Van Effelterre, T, et al.
Gepubliceerd in: (2010)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
door: Anita H J van den Biggelaar, et al.
Gepubliceerd in: (2017-01-01)

Vaccination of Icelandic children with the 10-valent pneumococcal vaccine leads to a significant herd effect among adults in Iceland
door: Quirk, S, et al.
Gepubliceerd in: (2019)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
door: Carina Valente, et al.
Gepubliceerd in: (2012-01-01)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
door: Shamez N. Ladhani, et al.
Gepubliceerd in: (2013-01-01)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
door: Victor Morais, et al.
Gepubliceerd in: (2022-12-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
door: Brueggemann, A, et al.
Gepubliceerd in: (2013)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
door: N. L. Chernaya, et al.
Gepubliceerd in: (2013-01-01)

State of the globe: Effect of pneumococcal conjugate vaccines on nonvaccine-type invasive pneumococcal disease
door: Sunil Kumar Raina
Gepubliceerd in: (2019-01-01)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
door: Ahmet Arvas, et al.
Gepubliceerd in: (2017-08-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
door: Brueggemann, AB, et al.
Gepubliceerd in: (2013)

VACCINE PREVENTION OF PNEUMOCOCCAL INFECTIONS IN ADULTS
door: A. A. Zaitsev, et al.
Gepubliceerd in: (2017-11-01)